Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does the Country Make a Difference in Impulse Control Disorders? A Systematic Review.
Parra-Díaz P, Chico-García JL, Beltrán-Corbellini Á, Rodríguez-Jorge F, Fernández-Escandón CL, Alonso-Cánovas A, Martínez-Castrillo JC. Parra-Díaz P, et al. Mov Disord Clin Pract. 2020 Dec 21;8(1):25-32. doi: 10.1002/mdc3.13128. eCollection 2021 Jan. Mov Disord Clin Pract. 2020. PMID: 33426155 Free PMC article. Review.
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study.
Monreal E, Sainz de la Maza S, Natera-Villalba E, Beltrán-Corbellini Á, Rodríguez-Jorge F, Fernández-Velasco JI, Walo-Delgado P, Muriel A, Zamora J, Alonso-Canovas A, Fortún J, Manzano L, Montero-Errasquín B, Costa-Frossard L, Masjuan J, Villar LM; COVID-HRC group. Monreal E, et al. Eur J Clin Microbiol Infect Dis. 2021 Apr;40(4):761-769. doi: 10.1007/s10096-020-04078-1. Epub 2020 Oct 20. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33083917 Free PMC article.
Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19: A pilot study.
Monreal E, Maza S S, Gullón P, Natera-Villalba E, Chico-García JL, Beltrán-Corbellini Á, Martínez-Sanz J, García-Barragán N, Buisán J, Toledano R, Alonso-Canovas A, Pérez-Torre P, Matute-Lozano MC, López-Sendón JL, García-Ribas G, Corral Í, Fortún J, Montero-Errasquín B, Manzano L, Máiz-Carro L, Costa-Frossard L, Masjuan J; COVID-HRC Group. Monreal E, et al. J Med Virol. 2021 Apr;93(4):2243-2251. doi: 10.1002/jmv.26656. Epub 2020 Nov 22. J Med Virol. 2021. PMID: 33165922
The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19.
Monreal E, Sainz de la Maza S, Fernández-Velasco JI, Natera-Villalba E, Rita CG, Rodríguez-Jorge F, Beltrán-Corbellini Á, Iturrieta-Zuazo I, Rodríguez de Santiago E, Espiño M, de Andrés A, Fortún J, Barbero E, Vázquez M, Fernández Lucas M, Manzano L, Montero-Errasquín B, Costa-Frossard L, Masjuan J, Villar LM; COVID-HRC group. Monreal E, et al. J Clin Immunol. 2021 Feb;41(2):315-323. doi: 10.1007/s10875-020-00927-y. Epub 2020 Nov 24. J Clin Immunol. 2021. PMID: 33236261 Free PMC article.
Malignant Left Atrial Appendage Morphology: Current Classification vs H-L System.
Parra-Díaz P, Salido-Tahoces L, Pardo-Sanz A, Beltrán-Corbellini Á, Rodríguez-Jorge F, Chico-García JL, García-Madrona S, Matute-Lozano C, Vera-Lechuga R, Cruz-Culebras A, Masjuan J, DeFelipe-Mimbrera A. Parra-Díaz P, et al. J Stroke Cerebrovasc Dis. 2021 Mar;30(3):105570. doi: 10.1016/j.jstrokecerebrovasdis.2020.105570. Epub 2020 Dec 30. J Stroke Cerebrovasc Dis. 2021. PMID: 33387891
SURINPARK: Safinamide for Urinary Symptoms in Parkinson's Disease.
Gómez-López A, Sánchez-Sánchez A, Natera-Villalba E, Ros-Castelló V, Beltrán-Corbellini Á, Fanjul-Arbós S, Pareés Moreno I, López-Sendon Moreno JL, Martínez Castrillo JC, Alonso-Canovas A. Gómez-López A, et al. Brain Sci. 2021 Jan 6;11(1):57. doi: 10.3390/brainsci11010057. Brain Sci. 2021. PMID: 33418858 Free PMC article.
Efficacy and safety of high doses of safinamide in advanced Parkinson disease.
Rodríguez-Jorge F, Beltrán-Corbellini Á, Chico-García JL, Parra-Díaz P, Baena-Álvarez B, Pagonabarraga J, Pérez-Torre P, Pareés I, López-Sendón JL, Martínez-Castrillo JC, Alonso-Cánovas A. Rodríguez-Jorge F, et al. Parkinsonism Relat Disord. 2022 Apr;97:73-74. doi: 10.1016/j.parkreldis.2022.03.010. Epub 2022 Mar 23. Parkinsonism Relat Disord. 2022. PMID: 35344893 No abstract available.
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis.
Singh B, Lant S, Cividini S, Cattrall JWS, Goodwin LC, Benjamin L, Michael BD, Khawaja A, Matos AMB, Alkeridy W, Pilotto A, Lahiri D, Rawlinson R, Mhlanga S, Lopez EC, Sargent BF, Somasundaran A, Tamborska A, Webb G, Younas K, Al Sami Y, Babu H, Banks T, Cavallieri F, Cohen M, Davies E, Dhar S, Fajardo Modol A, Farooq H, Harte J, Hey S, Joseph A, Karthikappallil D, Kassahun D, Lipunga G, Mason R, Minton T, Mond G, Poxon J, Rabas S, Soothill G, Zedde M, Yenkoyan K, Brew B, Contini E, Cysique L, Zhang X, Maggi P, van Pesch V, Lechien J, Saussez S, Heyse A, Brito Ferreira ML, Soares CN, Elicer I, Eugenín-von Bernhardi L, Ñancupil Reyes W, Yin R, Azab MA, Abd-Allah F, Elkady A, Escalard S, Corvol JC, Delorme C, Tattevin P, Bigaut K, Lorenz N, Hornuss D, Hosp J, Rieg S, Wagner D, Knier B, Lingor P, Winkler AS, Sharifi-Razavi A, Moein ST, SeyedAlinaghi S, JamaliMoghadamSiahkali S, Morassi M, Padovani A, Giunta M, Libri I, Beretta S, Ravaglia S, Foschi M, Calabresi P, Primiano G, Servidei S, Biagio Mercuri N, Liguori C, Pierantozzi M, Sarmati L, Boso F, Garazzino S, Mariotto S, Patrick KN, Costache O, Pincherle A, Klok FA, Meza R, Cabreira V, Valdoleiros SR, Oliveira V, Kaimovsky I, Guek… See abstract for full author list ➔ Singh B, et al. Among authors: beltran corbellini a. PLoS One. 2022 Jun 2;17(6):e0263595. doi: 10.1371/journal.pone.0263595. eCollection 2022. PLoS One. 2022. PMID: 35653330 Free PMC article.
23 results